NHIV

NewHold Investment Corp IV Class A Ordinary Shares

There isn't enough reported data to score NHIV yet.

NHIV Fundamentals

MetricStatus
Unavailable
Unavailable
N/A
N/A

There isn't enough reported data to rate NHIV's fundamentals.

NHIV PE Valuation

NHIV has no meaningful PE right now: it lost money over the past year.

NHIV Forward outlook

There aren't enough analyst estimates for NHIV to show an outlook.

NHIV Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $9.99 on Nov 12.

There is not enough scenario data to assess NHIV's risk to reward.

NHIV Earnings Per Share

NHIV Quarterly Revenue

Q3 2026: --
Q3 2026: --

NHIV Free Cash Flow

Q3 2026: −$238,000
Q3 2026: −$238,000

NHIV Total Shares

Q3 2026: 27M
Q3 2026: 27M

NHIV Net Leverage

NHIV Weekly Momentum

MetricValueStatus
RSI61.7Neutral
Stochastic17.4Oversold

NHIV's weekly RSI is 62 (neutral) and its Stochastic is 17 (oversold).

NHIV PE vs Financial Services Sector

NHIV has no meaningful PE right now: it lost money over the past year.

NHIV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.00.3% below
20 week MA$10.10.8% below

NHIV is in a downtrend: it's below all two of its weekly moving averages, and 0.8% below its 20-week average.

NHIV Yearly ROI

YearStart priceEnd priceROI
2026 YTD$9.95$9.99+0.4%

It's roughly flat so far in 2026.

Give your agent the market.

Get API key